Correction to: SEOM clinical guidelines for anaemia treatment in cancer patients (2020)

Correction to: Clinical and Translational Oncology 10.1007/s12094-021-02580-2

In Table 4 of this article, there were few mistakes and the corrected Table 4 is given below.

Table 4.

Iron compounds and approved dosages in patients with solid tumors and haematologic malignancies

Compound	Iron sucrose	Low molecular weight dextran iron	Ferric carboxymaltose
Test dose	Medical judgement, depending on the risk of reaction	Slow infusion of 25 mg over 15 min	Medical judgement, depending on the risk of reaction
Dosage	Dose: 200 mg IV in 100 mL sodium chloride 0.9% over 30–60 min (not more than 3 times per week) or 200 mg IV over 10 min, 5 times in 14 days. Total dose = 1000 mg	100–200 mg IV over 30 min Repeat dosing once a week for 10 doses for a total of 1000 mg or Full dose infusion over 4–6 h (total dose calculated in 500 mL. 0.9% NaCl solution at 175 mL/h)	Hb < 10 g/dL in patients 35 to < 70 kg 1500 mg IV; in patients ≥ 70 kg 2000 mg IV Hb > 10 g/dL in patients 35 to < 70 kg 1000 mg IV; in patients ≥ 70 kg 1500 mg IV A maximum single dose of 20 mg/kg body weight (intravenous drip infusion) or 15 mg/kg body weight (intravenous injection) up to 1000 mg of iron can be administered. Administration time: 15 min. Do not administered 1000 mg of iron more than once per week